![](/img/cover-not-exists.png)
Women with large (≥3 cm) and locally advanced breast cancers (T3, 4, N1, 2, M0) receiving neoadjuvant chemotherapy (NAC: cyclophosphamide, doxorubicin, docetaxel): addition of capecitabine improves 4-year disease-free survival
Eremin, Jennifer, Cowley, Ged, Walker, Leslie G, Murray, Elisabeth, Stovickova, Monika, Eremin, OlegVolume:
4
Year:
2015
Language:
english
Journal:
SpringerPlus
DOI:
10.1186/2193-1801-4-9
File:
PDF, 763 KB
english, 2015